ASP Isotopes (NASDAQ:ASPI) Releases Earnings Results, Misses Expectations By $0.11 EPS

ASP Isotopes (NASDAQ:ASPI) issued its earnings results on Friday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11), Zacks reports. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

ASP Isotopes Stock Performance

Shares of ASPI traded down $0.01 during mid-day trading on Friday, hitting $4.27. 1,941,410 shares of the company’s stock were exchanged, compared to its average volume of 4,927,466. The firm has a market cap of $654.63 million, a price-to-earnings ratio of -2.05 and a beta of 3.61. ASP Isotopes has a 52 week low of $3.51 and a 52 week high of $14.49. The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69. The stock’s 50-day simple moving average is $5.23 and its 200-day simple moving average is $5.44.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $13.00.

Insider Activity at ASP Isotopes

In related news, CFO Heather Kiessling sold 23,124 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $6.28, for a total value of $145,218.72. Following the transaction, the chief financial officer owned 1,526,252 shares in the company, valued at approximately $9,584,862.56. This trade represents a 1.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Elliot Mann sold 83,759 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $7.76, for a total value of $649,969.84. Following the completion of the transaction, the chief executive officer directly owned 9,579,845 shares of the company’s stock, valued at approximately $74,339,597.20. This trade represents a 0.87% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 279,079 shares of company stock worth $2,049,208 in the last quarter. 14.40% of the stock is currently owned by corporate insiders.

Institutional Trading of ASP Isotopes

Institutional investors and hedge funds have recently modified their holdings of the business. Integrated Wealth Concepts LLC bought a new stake in shares of ASP Isotopes during the 4th quarter valued at approximately $99,000. Tocqueville Asset Management L.P. bought a new position in ASP Isotopes in the 4th quarter valued at approximately $91,000. J.W. Cole Advisors Inc. bought a new position in ASP Isotopes in the 4th quarter valued at approximately $85,000. Legal & General Group Plc boosted its position in ASP Isotopes by 30.4% in the third quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after buying an additional 1,953 shares in the last quarter. Finally, B. Riley Wealth Advisors Inc. bought a new stake in shares of ASP Isotopes during the second quarter worth $121,000. 16.80% of the stock is currently owned by institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.